Numerous trials of haemostatic and neuroprotective agents for intracerebral haemorrhage (ICH) have failed. We characterized the risk of complications after ICH in a trial-eligible patient population, to inform safety in future trials. We used the Virtual International Stroke Trials Archive database to identify placebo-treated patients with spontaneous ICH, who were not comatose at admission, where randomization took place within 4 h of symptom onset, and where serious complication and outcome data were available. We described the complications encountered and assessed whether the absence of common complications influenced attainment of good functional outcome (mRS =4) at 90 days using logistic regression.
- intracerebral haemorrhage
- clinical trials
Ali, M., Lyden, P. L., Sacco, R., Shuaib, A., & Lees, K. R. (2009). Natural history of complications after intracerebral haemorrhage. European Journal of Neurology, 16(5), 624-630. https://doi.org/10.1111/j.1468-1331.2009.02559.x